CEO and President,
Zero Gravity Life Sciences, Inc.
Mr. Koopman is responsible for the development and execution of a strategic plan of business development for Zero Gravity Life Sciences, Inc., including complimentary and supportive activities for BAM Agricultural Solutions, Inc. as well as new corporate initiatives. In his former postion as Director of New Ventures at New York University in the Office of Industrial Liaison, Mr. Koopman worked with investors and entrepreneurs to facilitate the formation of new life science companies that focused on the development and commercialization of NYU technologies. In addition to almost 15 years in academic technology transfer, he has 16 years of varied experience in the biotechnology industry. He has held scientist, laboratory supervisor, and project manager positions in the course of his employment at two successful biotechnology startup companies, as well as Johnson & Johnson and Hoffman-LaRoche. During this period he was involved in the development of several therapeutic and diagnostic products which are currently on the market. Prior to joining the NYU Office of Industrial Liaison, Mr. Koopman was the Managing Director of Biomedical and Biotechnology Industries at Beroff Associates, a merchant investment banking and strategic advisory group. He has also provided consulting to a number of startup companies, investment groups, and public agencies regarding technology assessment and market analysis. Andrew received a B.S. in Biology from Binghamton University, an M.S. in molecular biology from Seton Hall University with a minor in business administration at the Stillman School of Business and is a proud alum of Stuyvesant High School in New York City.